Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hauke Walter

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Tenofovir resistance and resensitizationKatharina Wolf, Hauke Walter, Niko Beerenwinkel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 9, 2010
Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patientsKarin J Metzner, Pia Rauch, Patrick Braun, et al.
AIDS Research and Therapy|February 15, 2011
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?Frank Wiesmann, Jan Vachta, Robert Ehret, et al.
Journal of Virological Methods|October 15, 2016
Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitorsEva Heger, Alexandra Andrée Theis, Klaus Remmel, et al.
AIDS Reviews|May 19, 2011
European recommendations for the clinical use of HIV drug resistance testing: 2011 updateAnne-Mieke Vandamme, Ricardo J Camacho, Francesca Ceccherini-Silberstein, et al.
Journal of Virology|January 5, 2007
Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 proteaseSandra M Mueller, Birgit Schaetz, Kathrin Eismann, et al.
Plos One|May 20, 2016
Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral AgentsPrabhav Kalaghatgi, Anna Maria Sikorski, Elena Knops, et al.
Intervirology|January 31, 2012
HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledgeMartin Obermeier, Alejandro Pironti, Thomas Berg, et al.
Bioinformatics (Oxford, England)|September 8, 2005
Computational methods for the design of effective therapies against drug resistant HIV strainsNiko Beerenwinkel, Tobias Sing, Thomas Lengauer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2010
Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognitionSandra M Mueller, Bernd M Spriewald, Silke Bergmann, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Tenofovir resistance and resensitizationKatharina Wolf, Hauke Walter, Niko Beerenwinkel, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 9, 2010
Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patientsKarin J Metzner, Pia Rauch, Patrick Braun, et al.
AIDS Research and Therapy|February 15, 2011
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?Frank Wiesmann, Jan Vachta, Robert Ehret, et al.
Journal of Virological Methods|October 15, 2016
Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitorsEva Heger, Alexandra Andrée Theis, Klaus Remmel, et al.
AIDS Reviews|May 19, 2011
European recommendations for the clinical use of HIV drug resistance testing: 2011 updateAnne-Mieke Vandamme, Ricardo J Camacho, Francesca Ceccherini-Silberstein, et al.
Journal of Virology|January 5, 2007
Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 proteaseSandra M Mueller, Birgit Schaetz, Kathrin Eismann, et al.
Plos One|May 20, 2016
Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral AgentsPrabhav Kalaghatgi, Anna Maria Sikorski, Elena Knops, et al.
Intervirology|January 31, 2012
HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledgeMartin Obermeier, Alejandro Pironti, Thomas Berg, et al.
Bioinformatics (Oxford, England)|September 8, 2005
Computational methods for the design of effective therapies against drug resistant HIV strainsNiko Beerenwinkel, Tobias Sing, Thomas Lengauer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 26, 2010
Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognitionSandra M Mueller, Bernd M Spriewald, Silke Bergmann, et al.
Pageof 4